Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1981 Jun;11(6):565–570. doi: 10.1111/j.1365-2125.1981.tb01172.x

The early and late effects of digoxin treatment on the sodium transport, sodium content and Na+K+- ATPase or erythrocytes.

M Cumberbatch, K Zareian, C Davidson, D B Morgan, R Swaminathan
PMCID: PMC1402206  PMID: 6268133

Abstract

1 Erythrocyte sodium content, sodium transport (ouabain sensitive sodium flux Eos, and ouabain sensitive efflux rate constant ERCos) sodium, potassium activated ouabain sensitive adenosine triphosphatase (Na+K+ATPase) and plasma digoxin were measured in patients during acute digitalisation and in patients who were on long-term digoxin treatment. 2 In the six patients who were studied during digitalisation, the ERCos and Na+K+ATPase activity decreased and erythrocyte sodium content increased during days 2-4 treatment, but there was no change in Eos. 3 In 39 patients on long term digoxin therapy (2-119 months) the erythrocyte sodium content was normal, but the erythrocyte Na+K+ATPase activity was higher than the control group. When the results from these 39 patients were divided according to the duration of treatment it was found that the erythrocyte sodium content was higher in patients treated for 2-4 months than in patients treated for longer periods and the erythrocyte Na+K+ATPase activity increased with duration of treatment. In eight patients (duration of treatment greater than 29 months) in whom ERCos and Eos were measured, ERCos and Eos were higher than the control group. 4 The results suggest that the effects of digoxin on erythrocytes which occur during acute digoxin treatment do not persist in the long term. 5 The possible explanation for the higher ERCos, Eos and Na+K+ATPase activity in patients treated with digoxin for more than 2 months is discussed.

Full text

PDF
565

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akera T., Brody T. M. The role of Na+,K+-ATPase in the inotropic action of digitalis. Pharmacol Rev. 1977 Sep;29(3):187–220. [PubMed] [Google Scholar]
  2. Astrup J. The effect of hypokalaemia and of digoxin therapy on red cell sodium and potassium content. Some clinical aspects. Scand J Clin Lab Invest. 1974 Feb;33(1):11–16. doi: 10.3109/00365517409114191. [DOI] [PubMed] [Google Scholar]
  3. Bluschke V., Bonn R., Greeff K. Increase in the (Na+ + K+)-ATPase activity in heart muscle after chronic treatment with digitoxin or potassium deficient diet. Eur J Pharmacol. 1976 May;37(1):189–191. doi: 10.1016/0014-2999(76)90021-2. [DOI] [PubMed] [Google Scholar]
  4. Cumberbatch M., Morgan B. A simple technique for the measurement of ouabain-sensitive sodium transport in red cells. Clin Chim Acta. 1978 Oct 16;89(2):221–230. doi: 10.1016/0009-8981(78)90320-0. [DOI] [PubMed] [Google Scholar]
  5. Dunham P. B., Hoffman J. F. Partial purification of the ouabain-binding component and of Na,K-ATPase from human red cell membranes. Proc Natl Acad Sci U S A. 1970 Jul;66(3):936–943. doi: 10.1073/pnas.66.3.936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Erdmann E., Krawietz W. Increased number of ouabain binding sites in human erythrocyte membranes in chronic hypokalaemia. Acta Biol Med Ger. 1977;36(5-6):879–883. [PubMed] [Google Scholar]
  7. Ford A. R., Aronson J. K., Grahame-Smith D. G., Carver J. G. Changes in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients receiving digoxin during the early phases of treatment of cardiac failure in regular rhythm and of atrial fibrillation. Br J Clin Pharmacol. 1979 Aug;8(2):125–134. doi: 10.1111/j.1365-2125.1979.tb05810.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ford A. R., Aronson J. K., Grahame-Smith D. G., Carver J. G. The acute changes seen in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients during the early phases of digoxin therapy are not found during chronic therapy: pharmacological and therapeutic implications for chronic digoxin therapy. Br J Clin Pharmacol. 1979 Aug;8(2):135–142. doi: 10.1111/j.1365-2125.1979.tb05811.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. GLYNN I. M. The action of cardiac glycosides on sodium and potassium movements in human red cells. J Physiol. 1957 Apr 3;136(1):148–173. doi: 10.1113/jphysiol.1957.sp005749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Guz A., McHaffie D. The use of digitalis glycosides in sinus rhythm. Clin Sci Mol Med. 1978 Nov;55(5):417–421. doi: 10.1042/cs0550417. [DOI] [PubMed] [Google Scholar]
  11. Hoffman J. F. The red cell membrane and the transport of sodium and potassium. Am J Med. 1966 Nov;41(5):666–680. doi: 10.1016/0002-9343(66)90029-5. [DOI] [PubMed] [Google Scholar]
  12. Huang W-H, Askari A. Red cell Na+,K+-ATPase: a method for estimating the extent of inhibition of an enzyme sample containing an unknown amount of bound cardiac glycoside. Life Sci. 1975 Apr 15;16(8):1253–1261. doi: 10.1016/0024-3205(75)90310-0. [DOI] [PubMed] [Google Scholar]
  13. Kettlewell M., Nowers A., White R. Effect of digoxin on human red blood cell electrolytes. Br J Pharmacol. 1972 Jan;44(1):165–167. doi: 10.1111/j.1476-5381.1972.tb07250.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lawrence R. Assay of serum inorganic phosphate without deproteinisation: automated and manual micromethods. Ann Clin Biochem. 1974 Nov;11(6):234–237. doi: 10.1177/000456327401100168. [DOI] [PubMed] [Google Scholar]
  15. Loes M. W., Singh S., Lock J. E., Mirkin B. L. Relation between plasma and red-cell electrolyte concentrations and digoxin levels in children. N Engl J Med. 1978 Sep 7;299(10):501–504. doi: 10.1056/NEJM197809072991001. [DOI] [PubMed] [Google Scholar]
  16. Morgan D. B., Cumberbatch M., Cohn S., Scott D., Gunasuntharam T., Davidson C., Chapman C. The erythrocyte sodium and potassium in patients treated with digoxin. Br J Clin Pharmacol. 1980 Aug;10(2):127–133. doi: 10.1111/j.1365-2125.1980.tb01729.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wessels F., Samizadeh A., Losse H. Diagnose der Digitalisintoxikation durch Bestimmung der Erythrocyten-Elektrolyte. Klin Wochenschr. 1974 May 1;52(9):451–453. doi: 10.1007/BF01468587. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES